Stay updated on Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check33 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check61 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check76 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a clinical study on laryngeal cancer and the addition of a new study identifier and collaborators. The principal investigator's name and the revision number have also been updated.SummaryDifference22%
- Check83 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page.